Octreótido, tratamiento endoscópico o ambos en la hemorragia variceal activa enpacientes cirróticos: estudio multicéntrico
Background: Acute variceal bleeding in cirrhotic patients is an emergency with a high risk of rebleeding and death. Endoscopic procedures such as sclerotherapy or banding, combined or not with drugs such as octreotide could be considered. Aim: To assess the value of octreotide in the control of acut...
Guardado en:
Autores principales: | , , , , , , , , , , |
---|---|
Lenguaje: | Spanish / Castilian |
Publicado: |
Sociedad Médica de Santiago
2004
|
Materias: | |
Acceso en línea: | http://www.scielo.cl/scielo.php?script=sci_arttext&pid=S0034-98872004000300002 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
id |
oai:scielo:S0034-98872004000300002 |
---|---|
record_format |
dspace |
spelling |
oai:scielo:S0034-988720040003000022004-12-13Octreótido, tratamiento endoscópico o ambos en la hemorragia variceal activa enpacientes cirróticos: estudio multicéntricoSilva P,GuillermoQuera P,RodrigoFluxá G,FernandoSanhueza B,EdgarSegovia M,RobertoBrahm B,JavierMuñoz T,CristiánMorales B,AntonioMuñoz C,LorenaUrzúa F,LuisBiagini A,Leandro Esophageal and gastric varices Gastrointestinal hemorrhage Hypertension Octreotide Portal Background: Acute variceal bleeding in cirrhotic patients is an emergency with a high risk of rebleeding and death. Endoscopic procedures such as sclerotherapy or banding, combined or not with drugs such as octreotide could be considered. Aim: To assess the value of octreotide in the control of acute variceal bleeding. Patients and methods: Ninety-two patients were randomized into three groups: endoscopic therapy plus octreotide 50 µg/h bolus and continuous infusion for 5 days (n= 36); octreotide (same dosage) (n= 13) and endoscopic therapy only (banding and/or sclerotherapy) (n= 43). Results: Haemostasis at 24 hours was achieved in 97% of patients with combined treatment, 69% of patients receiving octreotide, and 93% of patients with endoscopic therapy (p= 0.2). Three patients with combined treatment, four patients receiving octreotide and eight patients with endoscopic therapy, rebled during the first five days (p= 0.15). The mean of blood units transfused was similar in the three groups. No differences were observed in hospital days and side effects. At 42 days of follow up, eight patients with endoscopic therapy, one patients with combined therapy and 2 patients receiving octreotide, died (p=NS). Conclusions: Octreotide is useful in the management of acute variceal bleeding. The absence of important side effects, renders it as a safe adjuvant treatment associated with endoscopic treatment (Rev Méd Chile 2004; 132: 285-94).info:eu-repo/semantics/openAccessSociedad Médica de SantiagoRevista médica de Chile v.132 n.3 20042004-03-01text/htmlhttp://www.scielo.cl/scielo.php?script=sci_arttext&pid=S0034-98872004000300002es10.4067/S0034-98872004000300002 |
institution |
Scielo Chile |
collection |
Scielo Chile |
language |
Spanish / Castilian |
topic |
Esophageal and gastric varices Gastrointestinal hemorrhage Hypertension Octreotide Portal |
spellingShingle |
Esophageal and gastric varices Gastrointestinal hemorrhage Hypertension Octreotide Portal Silva P,Guillermo Quera P,Rodrigo Fluxá G,Fernando Sanhueza B,Edgar Segovia M,Roberto Brahm B,Javier Muñoz T,Cristián Morales B,Antonio Muñoz C,Lorena Urzúa F,Luis Biagini A,Leandro Octreótido, tratamiento endoscópico o ambos en la hemorragia variceal activa enpacientes cirróticos: estudio multicéntrico |
description |
Background: Acute variceal bleeding in cirrhotic patients is an emergency with a high risk of rebleeding and death. Endoscopic procedures such as sclerotherapy or banding, combined or not with drugs such as octreotide could be considered. Aim: To assess the value of octreotide in the control of acute variceal bleeding. Patients and methods: Ninety-two patients were randomized into three groups: endoscopic therapy plus octreotide 50 µg/h bolus and continuous infusion for 5 days (n= 36); octreotide (same dosage) (n= 13) and endoscopic therapy only (banding and/or sclerotherapy) (n= 43). Results: Haemostasis at 24 hours was achieved in 97% of patients with combined treatment, 69% of patients receiving octreotide, and 93% of patients with endoscopic therapy (p= 0.2). Three patients with combined treatment, four patients receiving octreotide and eight patients with endoscopic therapy, rebled during the first five days (p= 0.15). The mean of blood units transfused was similar in the three groups. No differences were observed in hospital days and side effects. At 42 days of follow up, eight patients with endoscopic therapy, one patients with combined therapy and 2 patients receiving octreotide, died (p=NS). Conclusions: Octreotide is useful in the management of acute variceal bleeding. The absence of important side effects, renders it as a safe adjuvant treatment associated with endoscopic treatment (Rev Méd Chile 2004; 132: 285-94). |
author |
Silva P,Guillermo Quera P,Rodrigo Fluxá G,Fernando Sanhueza B,Edgar Segovia M,Roberto Brahm B,Javier Muñoz T,Cristián Morales B,Antonio Muñoz C,Lorena Urzúa F,Luis Biagini A,Leandro |
author_facet |
Silva P,Guillermo Quera P,Rodrigo Fluxá G,Fernando Sanhueza B,Edgar Segovia M,Roberto Brahm B,Javier Muñoz T,Cristián Morales B,Antonio Muñoz C,Lorena Urzúa F,Luis Biagini A,Leandro |
author_sort |
Silva P,Guillermo |
title |
Octreótido, tratamiento endoscópico o ambos en la hemorragia variceal activa enpacientes cirróticos: estudio multicéntrico |
title_short |
Octreótido, tratamiento endoscópico o ambos en la hemorragia variceal activa enpacientes cirróticos: estudio multicéntrico |
title_full |
Octreótido, tratamiento endoscópico o ambos en la hemorragia variceal activa enpacientes cirróticos: estudio multicéntrico |
title_fullStr |
Octreótido, tratamiento endoscópico o ambos en la hemorragia variceal activa enpacientes cirróticos: estudio multicéntrico |
title_full_unstemmed |
Octreótido, tratamiento endoscópico o ambos en la hemorragia variceal activa enpacientes cirróticos: estudio multicéntrico |
title_sort |
octreótido, tratamiento endoscópico o ambos en la hemorragia variceal activa enpacientes cirróticos: estudio multicéntrico |
publisher |
Sociedad Médica de Santiago |
publishDate |
2004 |
url |
http://www.scielo.cl/scielo.php?script=sci_arttext&pid=S0034-98872004000300002 |
work_keys_str_mv |
AT silvapguillermo octreotidotratamientoendoscopicooambosenlahemorragiavaricealactivaenpacientescirroticosestudiomulticentrico AT queraprodrigo octreotidotratamientoendoscopicooambosenlahemorragiavaricealactivaenpacientescirroticosestudiomulticentrico AT fluxagfernando octreotidotratamientoendoscopicooambosenlahemorragiavaricealactivaenpacientescirroticosestudiomulticentrico AT sanhuezabedgar octreotidotratamientoendoscopicooambosenlahemorragiavaricealactivaenpacientescirroticosestudiomulticentrico AT segoviamroberto octreotidotratamientoendoscopicooambosenlahemorragiavaricealactivaenpacientescirroticosestudiomulticentrico AT brahmbjavier octreotidotratamientoendoscopicooambosenlahemorragiavaricealactivaenpacientescirroticosestudiomulticentrico AT munoztcristian octreotidotratamientoendoscopicooambosenlahemorragiavaricealactivaenpacientescirroticosestudiomulticentrico AT moralesbantonio octreotidotratamientoendoscopicooambosenlahemorragiavaricealactivaenpacientescirroticosestudiomulticentrico AT munozclorena octreotidotratamientoendoscopicooambosenlahemorragiavaricealactivaenpacientescirroticosestudiomulticentrico AT urzuafluis octreotidotratamientoendoscopicooambosenlahemorragiavaricealactivaenpacientescirroticosestudiomulticentrico AT biaginialeandro octreotidotratamientoendoscopicooambosenlahemorragiavaricealactivaenpacientescirroticosestudiomulticentrico |
_version_ |
1718436138968940544 |